Skip to content
Open access

Expression characteristics of FAM20A in stomach adenocarcinoma and its potential as a prognostic marker

Oct 2026 · Oncology Letters · 0 citations · 44 references

Abstract

. Stomach adenocarcinoma (STAD) is a prevalent malignancy that is associated with high morbidity and mortality rates globally. Current therapeutic strategies are constrained by the limitations associated with early diag‑ nosis difficulties and personalized treatment approaches. Therefore, novel prognostic biomarkers are urgently needed to improve prognostic accuracy, facilitate risk stratification and guide personalized treatment decisions. Family with sequence similarity 20, member A ( FAM20A ) has also been implicated in lung squamous cell carcinoma and papillary thyroid carcinoma. In the present study, the expression levels and prognostic significance of FAM20A in STAD were investigated by performing bioinformatics analyses on data acquired from The Cancer Genome Atlas, Genotype‑Tissue Expression project and Human Protein Atlas databases. Survival analyses revealed that elevated levels of FAM20A expression associated with worse prognosis across several cancer types, including STAD (hazard ratio=1.636; P<0.01). Functional enrichment analyses indicated that genes associ‑ ated with FAM20A were enriched within immune‑related pathways (such as ‘immune response‑regulating signaling pathway’ and ‘regulation of immune effector process’), suggesting its involvement in modulating the tumor immune microenvironment. Furthermore, analysis using the TIMER database identified positive correlations between FAM20A expression and infiltration by macrophages and dendritic cells (DCs). In addition, macrophage and DCs infiltration levels in gastric cancer were associated with shorter survival in patients with STAD, which could impact patient survival outcomes. Experimental analysis further demonstrated that FAM20A facilitates the proliferation, migration and inva‑ sion of stomach cancer cells. In HGC‑27 gastric cancer cells transfected with a lentivirus overexpressing FAM20A or control lentivirus, a proliferation assay showed increased proliferation at 48 h, a wound‑healing assay showed enhanced migration, and a Transwell assay showed increased invasion compared with controls. These results suggest that FAM20A upregulation may promote the proliferation, migra‑ tion and invasion of gastric cancer cells. Collectively, these results emphasize the potential of FAM20A as a prognostic

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.